Business Context and Reporting Period
Company: Inter Parfums, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Nine months ended September 30, 2005
Business Overview: Inter Parfums manufactures, markets, and distributes fragrances, cosmetics, and health and beauty aids. Operations are split between European-based prestige brands (primarily Burberry, Celine, Christian Lacroix, Lanvin) and U.S.-based mass-market products. The company does not own manufacturing facilities, acting instead as a general contractor sourcing components from suppliers.
Key Financial Metrics
| Metric (Nine Months Ended Sept 30, 2005) | Value (in thousands) |
|---|---|
| Net Sales | $207,875 |
| Gross Margin | $117,529 (57% of sales) |
| Income from Operations | $23,243 (11.2% of sales) |
| Net Income | $11,371 |
| Diluted Earnings Per Share | $0.56 |
| Cash and Cash Equivalents | $26,355 |
| Short-term Investments | $17,700 |
| Total Current Assets | $199,082 |
| Total Current Liabilities | $70,139 |
| Working Capital | $128,943 |
| Long-term Debt (less current portion) | $10,597 |
| Cash Flow from Operating Activities | $7,707 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21% to $207.9 million compared to $172.2 million in the prior year period. Prestige product sales drove this growth, rising 29% to $184.2 million, while mass-market sales declined 18% to $23.7 million.
- Profitability: Despite revenue growth, Net Income decreased 7% to $11.4 million from $12.2 million. Operating income declined 7% to $23.2 million.
- Margin Expansion: Gross margin improved significantly from 50% to 57% of net sales, attributed to higher selling prices and cost-sharing adjustments for prestige lines.
- Expense Increase: Selling, General, and Administrative (SG&A) expenses surged 56% to $94.3 million (45% of sales vs. 35% prior year). This was primarily due to increased royalty payments (up 76%) and advertising expenditures (up 92%) under the new Burberry license agreement.
- Cash Flow: Operating cash flow turned positive at $7.7 million, a significant improvement from a $20.3 million outflow in the prior year, though accounts receivable increased 34% due to seasonal holiday buildup.
Guidance, Outlook, and Risks
- New Agreements: On July 14, 2005, the company entered an exclusive agreement with The Gap, Inc. to develop and distribute personal care and home fragrance products for Gap and Banana Republic. Initial products are expected to launch in late 2006/2007. Start-up costs are estimated at $1.5 million to $2.5 million for the remainder of 2005.
- Burberry License Impact: The new long-term Burberry license (effective 2004/2005) features royalty rates approximately double the prior agreement and higher advertising requirements. Management is adjusting the operating model (price increases, cost sharing) to mitigate the negative impact on the bottom line.
- Secondary Offering: On October 31, 2005, a major shareholder (LV Capital USA, Inc.) sold 3.4 million shares in a public offering. Inter Parfums received no proceeds from this transaction.
- Risks: Key risks include dependence on the Burberry license (61% of sales), renewal of license agreements, currency fluctuations, and the success of new product launches. The company notes that mass-market sales are pressured by high oil/gas prices affecting dollar store customers and sluggish economies in Latin America.
- Dividends: The board increased the quarterly cash dividend to $0.04 per share (approx. $3.2 million annually).
Investor Verification Checklist
- Burberry Dependency: Verify the sustainability of sales growth given that Burberry products represent over 60% of total revenue and the recent doubling of royalty rates.
- Gap Agreement Execution: Monitor the timeline and initial sales performance of the Gap/Banana Republic product lines launching in 2006-2007, and track associated start-up costs.
- Mass-Market Decline: Assess whether the 18% decline in mass-market sales is a temporary cyclical issue or a structural shift in the dollar store and export markets.
- Accounts Receivable: Review the 34% increase in accounts receivable relative to sales growth to ensure collection risks are managed, particularly in international markets.
- Shareholder Dilution: Note the recent secondary offering by LV Capital and the grant of warrants to Gap, which may impact future share count and ownership structure.